Search research articles
Contact Us
Filters
Showing results (51-60 of 416) with videos related to
Page
of 42
Sort By:
Drug Safety
|
July 1, 1993
Risks and benefits of drugs used in the management of the hyperactive child
A M Fox, M J Rieder
Methods in Molecular Medicine
|
February 19, 2011
Measurement of vascular density
A S Greene, M J Rieder
Frontiers in Pharmacology
|
May 17, 2021
Model Based Evaluation of Hypersensitivity Adverse Drug Reactions to Antimicrobial Agents in Children
Abdelbaset A Elzagallaai, Michael J Rieder
The Annals of Pharmacotherapy
|
August 6, 2000
Déjà vu all over again: adverse reactions to nonnucleoside reverse transcriptase inhibitors
M J Rieder, G A Dekaban
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|
July 8, 2008
Toxicity of a traditional Chinese medicine, Ganoderma lucidum, in children with cancer
Simperal K Gill, Michael J Rieder
British Journal of Clinical Pharmacology
|
September 10, 2014
In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology
Abdelbaset A Elzagallaai, Michael J Rieder
Lancet (London, England)
|
May 18, 1974
Letter: Myasthenic syndrome and subacute cerebellar degeneration
N K Blank, M J Rieder
The Annals of Pharmacotherapy
|
December 10, 1997
The role of reactive drug metabolites in immune-mediated adverse drug reactions
D A Hess, M J Rieder
Paediatrics & Child Health
|
March 22, 2021
The use of oral opioids to control children's pain in the post-codeine era
Michael J Rieder, Geert 't Jong
Paediatrics & Child Health
|
March 22, 2021
Les opioïdes par voie orale en remplacement de la codéine pour contrôler la douleur chez les enfants
Michael J Rieder, Geert 't Jong
Page
of 42
Search research articles
Search
Showing results (51-60 of 416) with videos related to
Sort By:
Page
of 42
Drug Safety
|
July 1, 1993
Risks and benefits of drugs used in the management of the hyperactive child
A M Fox, M J Rieder
Methods in Molecular Medicine
|
February 19, 2011
Measurement of vascular density
A S Greene, M J Rieder
Frontiers in Pharmacology
|
May 17, 2021
Model Based Evaluation of Hypersensitivity Adverse Drug Reactions to Antimicrobial Agents in Children
Abdelbaset A Elzagallaai, Michael J Rieder
The Annals of Pharmacotherapy
|
August 6, 2000
Déjà vu all over again: adverse reactions to nonnucleoside reverse transcriptase inhibitors
M J Rieder, G A Dekaban
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|
July 8, 2008
Toxicity of a traditional Chinese medicine, Ganoderma lucidum, in children with cancer
Simperal K Gill, Michael J Rieder
British Journal of Clinical Pharmacology
|
September 10, 2014
In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology
Abdelbaset A Elzagallaai, Michael J Rieder
Lancet (London, England)
|
May 18, 1974
Letter: Myasthenic syndrome and subacute cerebellar degeneration
N K Blank, M J Rieder
The Annals of Pharmacotherapy
|
December 10, 1997
The role of reactive drug metabolites in immune-mediated adverse drug reactions
D A Hess, M J Rieder
Paediatrics & Child Health
|
March 22, 2021
The use of oral opioids to control children's pain in the post-codeine era
Michael J Rieder, Geert 't Jong
Paediatrics & Child Health
|
March 22, 2021
Les opioïdes par voie orale en remplacement de la codéine pour contrôler la douleur chez les enfants
Michael J Rieder, Geert 't Jong
Page
of 42